Ontology highlight
ABSTRACT:
SUBMITTER: Divyang Deep Tiwari
PROVIDER: MODEL2310150001 | BioModels | 2023-11-17
REPOSITORIES: BioModels
Items per page: 5 1 - 5 of 7 |
Liu David D Schilling Bastian B Liu Derek D Sucker Antje A Livingstone Elisabeth E Jerby-Arnon Livnat L Zimmer Lisa L Gutzmer Ralf R Satzger Imke I Loquai Carmen C Grabbe Stephan S Vokes Natalie N Margolis Claire A CA Conway Jake J He Meng Xiao MX Elmarakeby Haitham H Dietlein Felix F Miao Diana D Tracy Adam A Gogas Helen H Goldinger Simone M SM Utikal Jochen J Blank Christian U CU Rauschenberg Ricarda R von Bubnoff Dagmar D Krackhardt Angela A Weide Benjamin B Haferkamp Sebastian S Kiecker Felix F Izar Ben B Garraway Levi L Regev Aviv A Flaherty Keith K Paschen Annette A Van Allen Eliezer M EM Schadendorf Dirk D
Nature medicine 20191202 12
Immune-checkpoint blockade (ICB) has demonstrated efficacy in many tumor types, but predictors of responsiveness to anti-PD1 ICB are incompletely characterized. In this study, we analyzed a clinically annotated cohort of patients with melanoma (n = 144) treated with anti-PD1 ICB, with whole-exome and whole-transcriptome sequencing of pre-treatment tumors. We found that tumor mutational burden as a predictor of response was confounded by melanoma subtype, whereas multiple novel genomic and transc ...[more]